Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 44.87%-11.07M | ---- | -719.59%-20.08M | ---- | 82.70%-2.45M | ---- | 36.07%-14.17M | ---- | 80.22%-22.16M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 59.69%-874K | ---- | -122.82%-2.17M | ---- | -278.60%-973K | ---- | 70.56%-257K | ---- | -59.89%-873K | ---- |
| Dividend (income)- adjustment | 31.87%-124K | ---- | 59.47%-182K | ---- | 29.73%-449K | ---- | -545.45%-639K | ---- | ---99K | ---- |
| Impairment and provisions: | 40.27%20.43M | ---- | 182.28%14.57M | ---- | -391.72%-17.7M | ---- | -115.33%-3.6M | ---- | -76.91%23.48M | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | --5.92M | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | 53.69%9.98M | ---- | 199.85%6.5M | ---- | 70.34%-6.51M | ---- | -207.98%-21.94M | ---- | 12.53%20.32M | ---- |
| -Other impairments and provisions | 29.45%10.45M | ---- | 172.08%8.07M | ---- | -190.16%-11.2M | ---- | 292.35%12.42M | ---- | -96.22%3.17M | ---- |
| Revaluation surplus: | -120.00%-2.08M | ---- | 264.49%10.37M | ---- | -1,864.49%-6.31M | ---- | 85.89%-321K | ---- | 44.81%-2.28M | ---- |
| -Other fair value changes | -120.00%-2.08M | ---- | 264.49%10.37M | ---- | -1,864.49%-6.31M | ---- | 85.89%-321K | ---- | 44.81%-2.28M | ---- |
| Asset sale loss (gain): | ---- | ---- | -735.89%-10.84M | ---- | 271.01%1.71M | ---- | -274.81%-997K | ---- | -175.35%-266K | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---11.25M | ---- | ---- | ---- | ---1M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | -76.07%408K | ---- | 42,525.00%1.71M | ---- | 101.50%4K | ---- | -175.35%-266K | ---- |
| Depreciation and amortization: | -23.65%3.33M | ---- | -6.97%4.37M | ---- | -22.59%4.69M | ---- | -22.35%6.06M | ---- | -67.58%7.81M | ---- |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -58.87%6.4M | ---- |
| Financial expense | -87.33%95K | ---- | -51.92%750K | ---- | -5.40%1.56M | ---- | -41.81%1.65M | ---- | -62.78%2.83M | ---- |
| Special items | -51.97%1.86M | ---- | 9,529.27%3.87M | ---- | 98.94%-41K | ---- | -49.81%-3.86M | ---- | 20.46%-2.57M | ---- |
| Operating profit before the change of operating capital | 1,680.62%11.57M | ---- | 103.26%650K | ---- | -23.82%-19.96M | ---- | -374.18%-16.12M | ---- | -57.42%5.88M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -16.67%-11.35M | ---- | -386.91%-9.73M | ---- | 153.64%3.39M | ---- | ---6.32M | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | 144.06%9.79M | ---- | 66.03%-22.22M | ---- | -285.30%-65.4M | ---- | -196.74%-16.97M | ---- | -19.45%17.55M | ---- |
| Accounts payable increase (decrease) | 84.94%-4.98M | ---- | -155.88%-33.04M | ---- | 987.71%59.13M | ---- | 195.15%5.44M | ---- | 61.46%-5.71M | ---- |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | 186.92%2.49M | ---- | -244.56%-2.87M | ---- | -65.47%1.98M | ---- |
| Special items for working capital changes | ---- | ---- | -69.34%8.2M | ---- | -28.28%26.76M | ---- | -45.26%37.31M | ---- | 271.39%68.16M | ---- |
| Cash from business operations | 85.74%-3.65M | ---- | -499.20%-25.6M | ---- | 1,306.14%6.41M | ---- | -99.48%456K | ---- | 762.85%87.85M | ---- |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | -183.51%-243K | ---- | 138.24%291K | ---- |
| China income tax paid | 26.21%-487K | ---- | -307.41%-660K | ---- | 73.95%-162K | ---- | -41.36%-622K | ---- | 86.88%-440K | ---- |
| Interest received - operating | -128.43%-8.68M | ---- | --30.54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of business | 128.43%8.68M | 54.80%-13.88M | ---30.54M | -226.05%-30.71M | ---- | 324.03%24.37M | ---- | -92.59%5.75M | ---- | 244.64%77.53M |
| Net cash from operations | 84.24%-4.14M | 54.80%-13.88M | -520.11%-26.26M | -226.05%-30.71M | 1,628.12%6.25M | 324.03%24.37M | -100.47%-409K | -92.59%5.75M | 604.98%87.71M | 244.64%77.53M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -59.69%874K | ---- | 122.82%2.17M | ---- | 278.60%973K | ---- | -70.56%257K | ---- | 59.89%873K | ---- |
| Dividend received - investment | -31.87%124K | ---- | -59.47%182K | ---- | -29.73%449K | ---- | 545.45%639K | ---- | --99K | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | 151.78%18.38M | ---- | --7.3M | ---- |
| Decrease in deposits (increase) | ---- | ---- | 198.62%6.09M | ---- | ---6.18M | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | 6.26%458K | ---- | -13.63%431K | ---- | -95.11%499K | ---- | 2,034.52%10.2M | ---- |
| Purchase of fixed assets | -19.12%-8.77M | ---- | 47.49%-7.36M | ---- | -411.08%-14.02M | ---- | 47.03%-2.74M | ---- | 44.82%-5.18M | ---- |
| Sale of subsidiaries | ---- | ---- | --8.83M | ---- | ---- | ---- | --1M | ---- | ---- | ---- |
| Recovery of cash from investments | -38.39%6.13M | ---- | --9.95M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | -46.32%-19.1M | ---- | ---13.05M | ---- | ---- | ---- | 200.00%9.71M | ---- | ---9.71M | ---- |
| Other items in the investment business | ---- | -232.11%-7.7M | ---- | 136.14%5.83M | ---- | -149.07%-16.13M | ---- | 3,209.93%32.87M | ---- | 79.68%-1.06M |
| Net cash from investment operations | -385.72%-20.74M | -232.11%-7.7M | 139.56%7.26M | 136.14%5.83M | -166.14%-18.35M | -149.07%-16.13M | 674.57%27.75M | 3,209.93%32.87M | 142.83%3.58M | 79.68%-1.06M |
| Net cash before financing | -30.97%-24.88M | 13.26%-21.58M | -57.00%-19M | -402.14%-24.88M | -144.26%-12.1M | -78.68%8.24M | -70.05%27.34M | -49.50%38.62M | 454.76%91.29M | 230.05%76.47M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | -98.48%545K | ---- | --35.95M | ---- | ---- | ---- | ---- | ---- |
| Refund | ---- | ---- | ---- | ---- | -76.76%-63.67M | ---- | ---36.02M | ---- | ---- | ---- |
| Interest paid - financing | ---- | ---- | 60.12%-554K | ---- | 23.17%-1.39M | ---- | 45.33%-1.81M | ---- | -85.27%-3.31M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---46.47M | ---- |
| Other items of the financing business | ---- | -166.26%-974K | ---1.99M | 113.59%1.47M | ---- | 70.01%-10.82M | 49.81%3.86M | 23.01%-36.07M | -20.46%2.57M | -86,668.52%-46.86M |
| Net cash from financing operations | 50.28%-1.95M | -166.26%-974K | 88.57%-3.91M | 113.59%1.47M | 6.10%-34.24M | 70.01%-10.82M | 26.11%-36.47M | 23.01%-36.07M | -3,779.95%-49.35M | -86,668.52%-46.86M |
| Effect of rate | 341.91%987K | -94.40%155K | 91.95%-408K | 139.89%2.77M | -231.39%-5.07M | -343.92%-6.93M | -148.79%-1.53M | -124.04%-1.56M | 255.00%3.13M | 45.24%6.5M |
| Net Cash | -17.09%-26.83M | 3.65%-22.56M | 50.56%-22.91M | -806.70%-23.41M | -407.58%-46.34M | -201.49%-2.58M | -121.77%-9.13M | -91.41%2.54M | 255.29%41.93M | 150.32%29.62M |
| Begining period cash | -22.19%81.76M | -22.19%81.76M | -32.85%105.08M | -32.85%105.08M | -6.38%156.49M | -6.38%156.49M | 36.92%167.15M | 36.92%167.15M | -19.21%122.08M | -19.21%122.08M |
| Cash at the end | -31.60%55.92M | -29.70%59.36M | -22.19%81.76M | -42.55%84.44M | -32.85%105.08M | -12.58%146.97M | -6.38%156.49M | 6.28%168.13M | 36.92%167.15M | 63.56%158.2M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Shin Yong Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.